(Q24235325)

6

0 references

author name string

Francesca Menchini

2

0 references

Vittoria Murro

3

0 references

Emanuela Peluso

4

0 references

Francesca Rosa

Cochrane Database of Systematic Reviews

5

0 references

publication date

6 July 2011

0 references

published in

0 references

cites work

Detection of diabetic foveal edema: contact lens biomicroscopy compared with optical coherence tomography.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008081.PUB2

Comparison of the clinical diagnosis of diabetic macular edema with diagnosis by optical coherence tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008081.PUB2

Optimal optical coherence tomography-based measures in the diagnosis of clinically significant macular edema: retinal volume vs foveal thickness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008081.PUB2

Comparison of time-domain OCT and fundus photographic assessments of retinal thickening in eyes with diabetic macular edema

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008081.PUB2

Retinal thickness in diabetic retinopathy: comparison of optical coherence tomography, the retinal thickness analyzer, and fundus photography

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008081.PUB2

Topography of diabetic macular edema with optical coherence tomography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008081.PUB2

Central retinal thickness measured with HD-OCT shows a weak correlation with visual acuity in eyes with CSME.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008081.PUB2

Automated detection of clinically significant macular edema by grid scanning optical coherence tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008081.PUB2

A systematic correlation of angiography and high-resolution optical coherence tomography in diabetic macular edema

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008081.PUB2

Retinal thickness in diabetic retinopathy: a study using optical coherence tomography (OCT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008081.PUB2

Quantitative assessment of retinal thickness in diabetic patients with and without clinically significant macular edema using optical coherence tomography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008081.PUB2

Optical coherence tomographic assessment of diabetic macular edema: comparison with fluorescein angiographic and clinical findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008081.PUB2

Perspectives on diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008081.PUB2

Relationship between optical coherence tomography retinal parameters and visual acuity in diabetic macular edema

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008081.PUB2

Comparative accuracy: assessing new tests against existing diagnostic pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008081.PUB2

The predictive value of patient and eye characteristics on the course of subclinical diabetic macular edema

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008081.PUB2

The relationship of macular thickness to clinically graded diabetic retinopathy severity in eyes without clinically detected diabetic macular edema

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008081.PUB2

A standardized method for reporting changes in macular thickening using optical coherence tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008081.PUB2

A phase II randomized double-masked trial of pegaptanib, an anti-vascular endothelial growth factor aptamer, for diabetic macular edema

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008081.PUB2

The performance of tests of publication bias and other sample size effects in systematic reviews of diagnostic test accuracy was assessed.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008081.PUB2

A phase II randomized clinical trial of intravitreal bevacizumab for diabetic macular edema

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008081.PUB2

Reproducibility of macular thickness and volume using Zeiss optical coherence tomography in patients with diabetic macular edema.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008081.PUB2

Relationship between optical coherence tomography-measured central retinal thickness and visual acuity in diabetic macular edema

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008081.PUB2

Optical coherence tomography measurements and analysis methods in optical coherence tomography studies of diabetic macular edema

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008081.PUB2

Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008081.PUB2

Meta-analysis of diagnostic test accuracy assessment studies with varying number of thresholds

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008081.PUB2

Evaluation of time domain and spectral domain optical coherence tomography in the measurement of diabetic macular edema

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008081.PUB2

Intravitreal steroids for macular edema in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008081.PUB2

A unification of models for meta-analysis of diagnostic accuracy studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008081.PUB2

Prospective comparison of cirrus and stratus optical coherence tomography for quantifying retinal thickness

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008081.PUB2

Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008081.PUB2

Fixation stability and macular light sensitivity in patients with diabetic maculopathy: a microperimetric study with a scanning laser ophthalmoscope

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008081.PUB2

Bias in sensitivity and specificity caused by data-driven selection of optimal cutoff values: mechanisms, magnitude, and solutions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008081.PUB2

Diagnostic test accuracy may vary with prevalence: implications for evidence-based diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008081.PUB2

Empirical evidence of design-related bias in studies of diagnostic tests

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008081.PUB2

Managing diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008081.PUB2

Antiangiogenic therapy with anti-vascular endothelial growth factor modalities for diabetic macular oedema

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008081.PUB2

Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008081.PUB2

Safety and efficacy of ranibizumab in diabetic macular edema (RESOLVE Study): a 12-month, randomized, controlled, double-masked, multicenter phase II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008081.PUB2

Case-control and two-gate designs in diagnostic accuracy studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008081.PUB2

Optical coherence tomography versus stereoscopic fundus photography or biomicroscopy for diagnosing diabetic macular edema: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008081.PUB2

The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008081.PUB2

Sources of variation and bias in studies of diagnostic accuracy: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008081.PUB2

Epidemiology of diabetic retinopathy and macular oedema: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008081.PUB2

Macular thickness measurements in healthy eyes using six different optical coherence tomography instruments

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008081.PUB2

When Should a New Test Become the Current Reference Standard?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008081.PUB2

Photocoagulation for Diabetic Macular Edema

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008081.PUB2

7 January 2021

The correlation between optical coherence tomographic features and severity of retinopathy, macular thickness and visual acuity in diabetic macular edema

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008081.PUB2

7 January 2021

Patterns of diabetic macular edema with optical coherence tomography

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008081.PUB2

7 January 2021

Detection of diabetic macular edema. Ophthalmoscopy versus photography--Early Treatment Diabetic Retinopathy Study Report Number 5. The ETDRS Research Group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008081.PUB2

7 January 2021

Cost effectiveness of current approaches to the control of retinopathy in type I diabetics

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008081.PUB2

7 January 2021

Diabetic maculopathy induced by vitreo-macular traction: evaluation by optical coherence tomography (OCT)

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008081.PUB2

7 January 2021

Indications for photocoagulation treatment of diabetic retinopathy: Diabetic Retinopathy Study Report no. 14. The Diabetic Retinopathy Study Research Group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008081.PUB2

7 January 2021

Diabetic Macular Edema: Correlation between Microperimetry and Optical Coherence Tomography Findings

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008081.PUB2

7 January 2021

Using the Principles of Randomized Controlled Trial Design to Guide Test Evaluation

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008081.PUB2

7 January 2021

Macular thickness measured by optical coherence tomography (OCT) in diabetic patients.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008081.PUB2

7 January 2021

https://api.crossref.org/works/10.1002%2F14651858.CD008081.PUB2

1 reference

7 January 2021

When is measuring sensitivity and specificity sufficient to evaluate a diagnostic test, and when do we need randomized trials?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008081.PUB2

7 January 2021

10.1002/14651858.CD008081.PUB2

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

Consolidated OpenCitations Corpus – April 2017

PubMed publication ID

21735421

1 reference

Consolidated OpenCitations Corpus – April 2017